CGP74514A enhances TRAIL-induced apoptosis in breast cancer cells by reducing X-linked inhibitor of apoptosis protein.
Sojung Park, Sang-Mi Shim, Sang-Hee Nam, Ladislav Andera, Nayoung Suh, Inki Kim
Index: Anticancer Res. 34(7) , 3557-62, (2014)
Full Text: HTML
Abstract
Despite the selectivity of Tumor necrosis factor Related Apoptosis-Inducing Ligand (TRAIL) for cancer cell killing activity, breast cancer cells are resistant to TRAIL-induced apoptosis for various reasons.From a functionally-characterized small-molecule dataset, CGP74514A was identified as a TRAIL sensitizer in MCF-7 breast cancer cells. Combination of sub-toxic dose of TRAIL with CGP74514A was evaluated in three TRAIL-resistant breast cancer cells, MCF-7, T47D and SK-BR-3.In all tested cells, CGP74514A enhanced TRAIL sensitivity. Combination treatment triggered apoptotic events faster than single treatment. Regarding its mechanism of action, CGP74514A reduced cytosolic X-linked inhibitor of apoptosis protein (XIAP). Small interfering RNA-mediated knockdown experiments showed that reduction of XIAP is the reason of sensitization.CGP74514A sensitized breast cancer cells to TRAIL via reduction of XIAP expression level.Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
Related Compounds
Related Articles:
2014-08-01
[Mol. Plant 7(8) , 1365-83, (2014)]
2014-12-11
[Oncogene 33(50) , 5688-96, (2014)]
2015-02-20
[Oncotarget 6(5) , 2604-14, (2015)]
2015-04-13
[Biomacromolecules 16(4) , 1382-9, (2015)]
2015-04-01
[J. Pineal Res. 58(3) , 310-20, (2015)]